ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 1 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,662 | +4.1% | 13,749 | -0.2% | 0.00% | 0.0% |
| Q2 2023 | $173,527 | +0.1% | 13,772 | +3.7% | 0.00% | 0.0% |
| Q1 2023 | $173,317 | +73967.1% | 13,281 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $234 | -99.9% | 13,281 | -0.1% | 0.00% | 0.0% |
| Q3 2022 | $202,000 | 0.0% | 13,292 | -2.6% | 0.00% | 0.0% |
| Q2 2022 | $202,000 | -32.4% | 13,652 | +2.8% | 0.00% | -25.0% |
| Q1 2022 | $299,000 | +22.0% | 13,281 | 0.0% | 0.00% | +33.3% |
| Q4 2021 | $245,000 | +37.6% | 13,281 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $178,000 | -27.6% | 13,281 | 0.0% | 0.00% | -33.3% |
| Q2 2021 | $246,000 | +23.6% | 13,281 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $199,000 | +3.6% | 13,281 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $192,000 | +77.8% | 13,281 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $108,000 | +20.0% | 13,281 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $90,000 | -7.2% | 13,281 | -3.5% | 0.00% | 0.0% |
| Q1 2020 | $97,000 | – | 13,769 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
| Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
| Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
| Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
| Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
| Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
| BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |